Argatroban Stroke Treatment - A Pilot Safety Study

Completed

Phase 1/2 Results

Summary of Purpose

Is the combination of low doses of argatroban in combination with rt-PA safe, and does it increase recanalization in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 November 2014.

1 Feb 2003 20 Dec 2005 1 Aug 2010 1 Aug 2010 1 Nov 2014 20 Aug 2012
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

Not available